133 related articles for article (PubMed ID: 34918615)
1. The relationship between cognitive impairment and superoxide dismutase activity in untreated first-episode patients with schizophrenia.
Wang DM; Du YX; Zhu RR; Tian Y; Chen JJ; Chen DC; Wang L; Zhang XY
World J Biol Psychiatry; 2022 Sep; 23(7):517-524. PubMed ID: 34918615
[No Abstract] [Full Text] [Related]
2. Association between MnSOD Activity and Cognitive Impairment in Unmedicated First-Episode Schizophrenia: Regulated by
Wang DM; Zhu RR; Tian Y; Uludag K; Chen JJ; Zhou HX; Wang L; Kosten TR; Zhang XY
Antioxidants (Basel); 2022 Oct; 11(10):. PubMed ID: 36290704
[TBL] [Abstract][Full Text] [Related]
3. Clinical symptoms and cognitive impairment associated with male schizophrenia relate to plasma manganese superoxide dismutase activity: a case-control study.
Zhang XY; Chen DC; Xiu MH; Tan YL; Yang FD; Zhang LY; Zhang LY; Haile CN; Kosten TR
J Psychiatr Res; 2013 Aug; 47(8):1049-53. PubMed ID: 23611682
[TBL] [Abstract][Full Text] [Related]
4. Cognition impairment in schizophrenia patients with tardive dyskinesia: association with plasma superoxide dismutase activity.
Wu JQ; Chen DC; Tan YL; Tan SP; Wang ZR; Xiu MH; Yang FD; Zhang XY
Schizophr Res; 2014 Jan; 152(1):210-6. PubMed ID: 24325977
[TBL] [Abstract][Full Text] [Related]
5. Elevated activity of superoxide dismutase in male late-life schizophrenia and its correlation with clinical symptoms and cognitive deficits.
Huo L; Lu X; Wu F; Chang C; Ning Y; Zhang XY
BMC Psychiatry; 2021 Dec; 21(1):606. PubMed ID: 34863137
[TBL] [Abstract][Full Text] [Related]
6. Sex-specific association between peripheral superoxide dismutase, BDNF and cognitive impairment in drug-naive first episode patients with schizophrenia.
Qu M; Wang J; Chen DC; Chen S; Xiu MH; Zhang XY
Free Radic Biol Med; 2020 Nov; 160():887-893. PubMed ID: 32949664
[TBL] [Abstract][Full Text] [Related]
7. Association of altered CuZn superoxide dismutase and cognitive impairment in schizophrenia patients with tardive dyskinesia.
Wu JQ; Chen DC; Tan YL; Tan S; Wang Z; Yang F; Soares JC; Zhang XY
J Psychiatr Res; 2014 Nov; 58():167-74. PubMed ID: 25151339
[TBL] [Abstract][Full Text] [Related]
8. Interrelationships Between BDNF, Superoxide Dismutase, and Cognitive Impairment in Drug-Naive First-Episode Patients With Schizophrenia.
Xiu MH; Li Z; Chen DC; Chen S; Curbo ME; Wu HE; Tong YS; Tan SP; Zhang XY
Schizophr Bull; 2020 Dec; 46(6):1498-1510. PubMed ID: 32390043
[TBL] [Abstract][Full Text] [Related]
9. Elevated activity of plasma superoxide dismutase in never-treated first-episode schizophrenia patients: Associated with depressive symptoms.
Lang X; Wang DM; Du XD; Jia QF; Chen DC; Xiu M; Wang L; Zhang X
Schizophr Res; 2020 Aug; 222():291-296. PubMed ID: 32451132
[TBL] [Abstract][Full Text] [Related]
10. Sex differences in the association between symptoms and superoxide dismutase in patients with never-treated first-episode schizophrenia.
Wang DM; Chen DC; Wang L; Zhang XY
World J Biol Psychiatry; 2021 Jun; 22(5):325-334. PubMed ID: 32772768
[TBL] [Abstract][Full Text] [Related]
11. Tardive dyskinesia is associated with greater cognitive impairment in schizophrenia.
Wu JQ; Chen DC; Xiu MH; Tan YL; Yang FD; Kosten TR; Zhang XY
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():71-7. PubMed ID: 23827756
[TBL] [Abstract][Full Text] [Related]
12. Cognitive Impairment and Psychopathology Are Related to Plasma Oxidative Stress in Long Term Hospitalized Patients With Chronic Schizophrenia.
Yang M; Li J; Yang H; Yan L; Liu D; Zhu L; Zhang X
Front Psychiatry; 2022; 13():896694. PubMed ID: 35757215
[TBL] [Abstract][Full Text] [Related]
13. Cognitive function, plasma MnSOD activity, and MnSOD Ala-9Val polymorphism in patients with schizophrenia and normal controls.
Zhang XY; Chen DC; Xiu MH; Yang FD; Tan Y; Luo X; Zuo L; Kosten TA; Kosten TR
Schizophr Bull; 2014 May; 40(3):592-601. PubMed ID: 23588476
[TBL] [Abstract][Full Text] [Related]
14. Sex difference in association between tardive dyskinesia and cognitive deficits in patients with chronic schizophrenia.
Zhang W; Wang D; Zhou H; Chen D; Xiu M; Cui L; Zhang X
Schizophr Res; 2023 May; 255():140-147. PubMed ID: 36989671
[TBL] [Abstract][Full Text] [Related]
15. Association of negative symptoms with cognitive impairment in Chinese Han patients with chronic schizophrenia.
Zhu R; Wang D; Wei G; Wang J; Zhou H; Xu H; Wang W; Wei S; Chen D; Xiu M; Wang L; Zhang XY
Int J Psychiatry Clin Pract; 2021 Sep; 25(3):292-298. PubMed ID: 33879034
[TBL] [Abstract][Full Text] [Related]
16. Sex difference in association between insomnia and cognitive impairment in patients with chronic schizophrenia.
Zhu R; Wang D; Tian Y; Du Y; Chen J; Zhou H; Chen D; Wang L; Alonzo BA; Emily Wu H; Yang Zhang X
Schizophr Res; 2022 Feb; 240():143-149. PubMed ID: 35026599
[TBL] [Abstract][Full Text] [Related]
17. Plasma total antioxidant status and cognitive impairments in schizophrenia.
Zhang XY; Chen DC; Xiu MH; Tang W; Zhang F; Liu L; Chen Y; Liu J; Yao JK; Kosten TA; Kosten TR
Schizophr Res; 2012 Aug; 139(1-3):66-72. PubMed ID: 22555016
[TBL] [Abstract][Full Text] [Related]
18. Age of Onset Moderates the Association between Total Antioxidant Capacity and Cognitive Deficits in Patients with Drug-Naïve Schizophrenia.
Li J; Li D; Guo J; Wang D; Zhang X
Antioxidants (Basel); 2023 Jun; 12(6):. PubMed ID: 37371989
[TBL] [Abstract][Full Text] [Related]
19. Superoxide Dismutase, BDNF, and Cognitive Improvement in Drug-Naive First-Episode Patients With Schizophrenia: A 12-Week Longitudinal Study.
Wu Z; Liu Q; Zhang Y; Guan X; Xiu M; Zhang X
Int J Neuropsychopharmacol; 2022 Feb; 25(2):128-135. PubMed ID: 34622272
[TBL] [Abstract][Full Text] [Related]
20. Association of depressive symptoms with cognitive impairment in patients with never-treated first-episode schizophrenia: Analysis of the Depression in Schizophrenia in China (DISC) study.
Chen XJ; Wang DM; Zhou HX; Zhu RR; Tian Y; Du YX; Chen JJ; Chen DC; Wang L; Zhang XY
Gen Hosp Psychiatry; 2021; 71():108-113. PubMed ID: 34000518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
